Respiratory distress syndrome (RDS) considered one of the most serious disorders which leading to high morbidities and mortalities among neonates. It occurs when a neonate's lungs aren't fully developed and unable to gain enough oxygen. The aim of this study was to determine the effect of clinical pathway on nursing care of neonates with respiratory distress syndrome. A quasi-experimental design was used. This study was carried out at neonatal intensive care units affiliated to Benha University Hospital and Benha specialized hospital of children and Benha Teaching Hospital at Benha city. A convenient sample of (150) nurses and all the available neonates with respiratory distress syndrome (150 neonates). Three tools were used;ToolI-A structured interviewing schedule, which consists of four parts: Nurses' characteristics, neonates' characteristics, Nurses' knowledge regarding neonatal respiratory distress syndrome, and Nurses' Knowledge about nursing care of neonates with Respiratory distress syndrome. Tool II-Clinical pathway of care checklist. Tool III-Neonatal clinical outcome assessment sheet. Results of this study revealed that, there was statistically significant differences regarding the effect of clinical pathway on the clinical outcomes of studied neonates pre and post clinical pathway implementation. This study concluded that: Implementation of the clinical pathway improved nurses' knowledge and practice that reflecting obvious improvement in clinical outcomes of neonates with respiratory distress syndrome. The study recommended that Clinical pathway on nursing care of neonates with respiratory distress should be applied for neonates with respiratory distress at different settings.
Introduction
Respiratory distress syndrome (RDS), formerly known as hyaline membrane disease. It is the most common cause of respiratory distress of the preterm neonates, because lung immaturity is associated with inadequate production of pulmonary surfactant. As, it is a result of surfactant deficiency, which causes increased surface tension in the air-liquid interface of the terminal respiratory units , which leading to atelectasis, increased ventilation perfusion mismatch, and potential lung injury due to a marked pulmonary inflammatory response (1) .
Respiratory distress syndrome in neonates
results from a combination of structural and functional immaturity of the lungs, as a result of the final unfolding of the alveolar septa, which increases the surface area of the lungs. Whereas, it occurs during the last trimester of pregnancy, Moreover, neonates are born with numerous underdeveloped and many uninflatable alveoli (2) . Clinically, RDS presents with early respiratory distress comprising; cyanosis, tachypnoea, intercostals, subcostal, and sternal recession, expiratory grunting, and diminished breath sounds. So that, any delay in diagnosis of airway abnormalities may be a life threatening (3) .
Respiratory distress syndrome primarily, considered a disease of preterm neonates, it also, can occur in those born close to or at term. It should be considered as a differential diagnosis in any neonate with early respiratory distress. In rare cases, neonates with RDS may suffer from genetic conditions such as; surfactant protein-B or ABCA3 deficiency. So, surfactant therapy considered one of the main parts of management (4) .
There are many factors can increase the risk of RDS include; one sibling had RDS, mothers suffering from diabetes, cesarean delivery or induction of labor problems with delivery that reduce blood flow to the neonate and multiple pregnancies (5 11, 193 .Whereas, the most cases of RDS occur in neonates born before 37 weeks. Additionally, the incidence of RDS increases with decreasing gestational age, especially infants born below 30 weeks gestation are at the greatest risk for RDS (7) .
Clinical pathway care is a structured, to medication administration (9) .
Significance of the Study:
The preterm birth is estimated by 10% -12% from neonates born in Egypt (9) . 
Aim of the study:
The aim of this study was to: Determine -Neonates with respiratory distress syndrome who will exposed to the clinical pathway will have less demand of oxygen, decreased frequency of daily suctioning, and decreased length of hospital stay.
Subjects and method:

Research Design:
A quasi-experimental research design was utilized.
Settings:
The study was carried out at neonatal weeks.
-The current weight from 1500 ≤ 2500 grams.
-Respiratory distress which manifested by the criteria a-Tachypnea more than 60c/m b-Having mild to moderate chest retraction.
Exclusion criteria:
Neonates with major malformation, congenital heart disease or on mechanical ventilation
Tools of Data Collection:
There were three tools utilized to collect the required data. Those tools as the following:
Tanta Scientific Nursing Journal The total score of nurses' knowledge were calculated and classified into three levels as following:
 60% will be considered poor knowledge.
 60-75% will be considered fair knowledge.
 75-100 % will be considered good knowledge. -Scoring System for practice of the studied nurses.
Scoring system for nurses performances will be as follows:
 Done correctly and complete will score (1)
 Done incorrect or not done well will score(0)
The total score of nurses' practice will calculated and classified as follow:
 60 to less than 75 will be considered unsatisfactory.
 75-100 % will be considered satisfactory Tool III-Neonates' medical outcomes assessment sheet: It was developed by the researchers to assess the improvement of neonates' condition after application of the clinical pathway. It included; feeding improvement, O 2 requirement, and length of hospital stay.
Preparatory phase:
Validity and Reliability
The researchers reviewed the past, current 
Method:
Exploratory phase:
Ethical considerations and human rights:
An official permission to conduct the study was obtained from the hospital mangers.
Then participation in the study was voluntary; each nurse was informed about the purpose, procedure, benefits, and nature of the study and each nurse had the right to withdraw from the study at any time without any rationale, then oral/written consent obtained from them.
Subjects were informed that obtained data will not be included in any further researches. Confidentiality and anonymity of each subject was assured through coding of all data and all information has taken was protected.
Pilot Study:
It was conducted on 10 % of the total study  P-value ≤ 05 to be statistically significant.
 P-value ≤ 001 to be high statistically significant.
Evaluation Phase:
Upon the completion of the clinical pathway implementation, the post test evaluation was conducted to evaluate the outcomes by using the same pre test tools Results: (18) who found that an obvious improvement in practice scores of the study group subjects immediately post nursing clinical pathway implementation than pre-nursing clinical pathway implementation. Additionally, Hussein, (2014) (17) The results of the current study are supported by Patrick (2006) (21) who found that in her study that there was a statistical 
